

Westerlin Drugs Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
- Paid Up Capital ₹ 0.12 M
- Company Age 34 Year, 2 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 7.40 M
- Revenue Growth 41.91%
- Profit Growth -394.75%
- Ebitda 34.08%
- Net Worth -69.79%
- Total Assets 6.09%
About Westerlin Drugs
Westerlin Drugs Private Limited (WDPL) is a Private Limited Indian Non-Government Company incorporated in India on 28 December 1990 and has a history of 34 years and two months. Its registered office is in Patna, Bihar, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 0.12 M.
The company currently has active open charges totaling ₹7.40 M.
Sunil Kumar, Subhash Singh, and Lakshmi Jha serve as directors at the Company.
Company Details
- Location
Patna, Bihar, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U00304BR1990PTC004286
- Company No.
004286
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
28 Dec 1990
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Patna
Industry
What products or services does Westerlin Drugs Private Limited offer?
Westerlin Drugs Private Limited offers a wide range of products and services, including Anti Infective Drugs & Medicines, Antibiotic Tablets, Capsule & Syrup, Cardiovascular Drugs & Medication, Cholesterol Medicine, Antiparasitic Drug, Nutraceuticals & Dietary Supplements, Multivitamin Syrup & Drops, Digestive System Drugs & Medicines, Antacid Drugs, Antibacterial Drugs.
Who are the key members and board of directors at Westerlin Drugs?
Board Members (3)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Sunil Kumar ![]() | Director | 01-Oct-2015 | Current |
Subhash Singh ![]() | Director | 01-Oct-2015 | Current |
Lakshmi Jha ![]() | Director | 15-Dec-2022 | Current |
Financial Performance of Westerlin Drugs.
Westerlin Drugs Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 41.91% increase. The company also saw a substantial fall in profitability, with a 394.75% decrease in profit. The company's net worth observed a substantial decline by a decrease of 69.79%.


- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Westerlin Drugs?
In 2023, Westerlin Drugs had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Related Corporates (Common Directorship)
- Saroj Mother & Child Care Centre Private Limited
Sunil Kumar, Subhash Singh and 1 more are mutual person
Charges (Loans)
₹7.40 M
₹0
Charges Breakdown by Lending Institutions
- State Bank Of India : 0.74 Cr
Latest Charge Details
Date | Lender | Amount | Status |
---|---|---|---|
20 Oct 2022 | State Bank Of India | ₹7.40 M | Open |
How Many Employees Work at Westerlin Drugs?
Unlock and access historical data on people associated with Westerlin Drugs, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Westerlin Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Westerlin Drugs's trajectory.
Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Latest Updates, News, and FAQs on Westerlin Drugs
Recent activity within the organization
- Annual General Meeting
Westerlin Drugs Private Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records.
- Balance Sheet
Westerlin Drugs Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Patna.
- Director Appointment
Lakshmi Jha was appointed as a Director was appointed as a Director on 15 Dec 2022 & has been associated with this company since 2 years 3 months .
- Charges
A charge with State Bank Of India amounted to Rs. 7.40 M with Charge ID 100628637 was registered on 20 Oct 2022.
- Director Appointment
Sunil Kumar was appointed as a Director was appointed as a Director on 01 Oct 2015 & has been associated with this company since 9 years 5 months .
- Director Appointment
Subhash Chandra Singh was appointed as a Director was appointed as a Director on 01 Oct 2015 & has been associated with this company since 9 years 5 months .
Frequently asked questions
What is the Incorporation or founding date of Westerlin Drugs Private Limited?
Westerlin Drugs Private Limited was incorporated on 28 Dec 1990.
What is authorized share capital and paid-up capital of Westerlin Drugs Private Limited?
The authorized share capital of Westerlin Drugs Private Limited is ₹ 5.00 M and paid-up capital is ₹ 0.12 M.
Who are the current board members & directors of Westerlin Drugs Private Limited?
Currently 3 directors are associated with Westerlin Drugs Private Limited.
- Sunil Kumar
- Subhash Chandra Singh
- Lakshmi Jha
What is the registered address of Westerlin Drugs Private Limited?
As per Ministry of Corporate Affairs (Mca), the registered address of Westerlin Drugs Private Limited is Nc-115 Sbi Officers Colony Lohia Nagar Kankarbagh, Patna, Bihar, India, 800020.
What is the corporate identification number (CIN) and company number of Westerlin Drugs Private Limited?
The corporate identification number (CIN) of Westerlin Drugs Private Limited is U00304BR1990PTC004286 and the company number is 004286 as per Ministry of Corporate Affairs (MCA).
What is the official website of Westerlin Drugs Private Limited?
The Official website of Westerlin Drugs Private Limited is https://www.westerlindrugs.com
What has been the recent revenue trend for Westerlin Drugs Private Limited?
According to the financial reports for the fiscal year 2023, the revenue trend for Westerlin Drugs Private Limited has risen by 41.91%.
What change has been observed in the net worth of Westerlin Drugs Private Limited, and by what percentage?
The financial reports for the fiscal year 2023 indicates that The net worth of Westerlin Drugs Private Limited has experienced an downturn of -69.79%.
What are the total open charges for Westerlin Drugs Private Limited?
As per the financial statements for fiscal Year 2023, The total open charges for Westerlin Drugs Private Limited amount to ₹ 7.40 M.
When was the last Balance Sheet of Westerlin Drugs Private Limited filed with the ROC?
The most recent Balance Sheet for Westerlin Drugs Private Limited was filed with the ROC on 31 Mar 2023.
Search company & director profiles for free and gain access to critical business data.
- 3.1M+ Companies
- 15M+ Legal Cases
- 525K+ Credit Ratings
- 5.8M+ Directors & KMP
- 750K+ Regulatory Alerts
- 1.1M+ Companies' Financial Records
People also Viewed
MS
Mamta SinhaDirectorSS
Suparna SinhaDirectorSS
Subhas SinhaManaging Director